首页> 外文期刊>Advances in therapy. >Need to improve thromboprophylaxis across the continuum of care for surgical patients.
【24h】

Need to improve thromboprophylaxis across the continuum of care for surgical patients.

机译:需要改善外科手术患者整个护理过程中的血栓预防措施。

获取原文
获取原文并翻译 | 示例
       

摘要

INTRODUCTION: Prophylaxis for venous thromboembolism (VTE) is underused following major surgery and frequently stopped at hospital discharge despite short stays and high VTE risk for several weeks postsurgery. We evaluated inpatient and postdischarge prophylaxis in patients who underwent major abdominal or orthopedic surgery. METHODS: Patient records were assessed for anticoagulant use by cross-matching data from the Premier's Perspective discharge database with the i3/Ingenix LabRx outpatient and inpatient database from January 2005 to December 2007. Abdominal or orthopedic surgery patients at risk of VTE according to the 2004 American College of Chest Physicians guidelines and with no contraindications to anticoagulation were included. RESULTS: A total of 14,009 eligible surgical discharges were analyzed. Only 27.9% of the 10,698 abdominal surgery patients received anticoagulation in hospital. Most inpatients received unfractionated heparin (12.3% of the total abdominal surgery population) or enoxaparin (11.8%). Of the 3311 orthopedic surgery patients, 91.1% received in-hospital anticoagulation. Similar proportions of patients received enoxaparin (32.1%), warfarin (31.1%), or other agents (28.0%). Only 1.2% of abdominal surgery patients had an anticoagulant prescription filled 30 days postdischarge. Although orthopedic surgery outpatients had higher anticoagulation rates, only 54.4% had filled a prescription 30 days postdischarge with 31.1% receiving warfarin, 18.5% receiving enoxaparin, and 4.8% receiving other anticoagulants. The higher prophylaxis rate in orthopedic patients may reflect the high VTE risk in orthopedic surgery patients and increased awareness among orthopedic surgeons. CONCLUSION: This real-world study highlights the underuse of thromboprophylaxis in hospitalized surgical patients, especially following abdominal surgery. Furthermore, a considerable proportion of these patients do not receive postdischarge anticoagulation despite guideline recommendations. Further efforts are needed to improve anticoagulant use, particularly in the outpatient setting.
机译:简介:大手术后预防静脉血栓栓塞症(VTE)的使用不足,尽管住院时间短且术后几周VTE风险高,但经常在出院时停止。我们评估了接受大腹部或骨科手术的患者的住院和出院后预防。方法:2005年1月至2007年12月,通过Premier透视出院数据库与i3 / Ingenix LabRx门诊病人和住院病人数据库的交叉匹配数据,对患者记录进行抗凝药物使用评估。根据2004年数据,有腹腔或骨科手术风险的VTE包括美国胸科医师学院指南,无抗凝禁忌症。结果:共分析了14009例符合条​​件的手术出院。在10698名腹部手术患者中,只有27.9%在医院接受抗凝治疗。大多数住院患者接受普通肝素(占腹部外科手术总人数的12.3%)或依诺肝素(11.8%)。在3311例骨科手术患者中,91.1%接受了院内抗凝治疗。接受依诺肝素(32.1%),华法林(31.1%)或其他药物(28.0%)的患者比例相似。出院后30天,只有1.2%的腹部手术患者有抗凝处方。尽管整形外科门诊患者的抗凝率较高,但出院后30天只有54.4%的人填写了处方,其中31.1%的患者接受华法林,18.5%的患者接受依诺肝素和4.8%的患者接受其他抗凝剂。骨科患者较高的预防率可能反映了骨科手术患者的高VTE风险和骨科医生的意识增强。结论:这项现实世界的研究突出了住院外科手术患者尤其是腹部手术患者对血栓预防的使用不足。此外,尽管有指南建议,但仍有相当一部分患者未接受出院后抗凝治疗。需要进一步努力改善抗凝剂的使用,尤其是在门诊患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号